--------- Emailed Dave with a list of questions. Not in talks...

---------
Emailed Dave with a list of questions.
Not in talks with the FDA on any matter bar the fully implantable.
(There goes one of my theories.)
But means there is no regulatory slowdown on trial.

Other comment was he couldn't tell me anymore, and he doesn't know why people are being so ridiculous.
----------
What have we got?
Given the science, it may take time, but it must flow through to enrolments.
Seem considerably de-risked by it.

Given the science, the market size, Clinician support are bankers going to be shy? don't think so.
Maybe its just the low we had to have.?